Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Personalis Inc (PSNL)

Personalis Inc (PSNL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,233,397
  • Shares Outstanding, K 38,933
  • Annual Sales, $ 65,210 K
  • Annual Income, $ -25,080 K
  • 60-Month Beta 1.68
  • Price/Sales 13.41
  • Price/Cash Flow N/A
  • Price/Book 5.32
Trade PSNL with:

Options Overview

Details
  • Implied Volatility 106.57%
  • Historical Volatility 69.08%
  • IV Percentile 57%
  • IV Rank 3.89%
  • IV High 1,299.42% on 03/16/20
  • IV Low 58.31% on 09/28/20
  • Put/Call Vol Ratio 3.11
  • Today's Volume 230
  • Volume Avg (30-Day) 420
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 5,841
  • Open Int (30-Day) 6,455

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.30
  • Number of Estimates 4
  • High Estimate -0.24
  • Low Estimate -0.38
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.88 +6.75%
on 02/26/21
43.97 -29.88%
on 02/03/21
-11.64 (-27.41%)
since 01/26/21
3-Month
25.60 +20.43%
on 11/30/20
53.46 -42.33%
on 01/20/21
+4.59 (+17.49%)
since 11/25/20
52-Week
4.27 +622.01%
on 03/17/20
53.46 -42.33%
on 01/20/21
+22.04 (+250.74%)
since 02/26/20

Most Recent Stories

More News
Personalis: 4Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Personalis Inc. (PSNL) on Thursday reported a loss of $13.3 million in its fourth quarter.

PSNL : 30.83 (-2.68%)
First Week of October 15th Options Trading For Personalis (PSNL)

Investors in Personalis Inc saw new options become available this week, for the October 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the...

PSNL : 30.83 (-2.68%)
Natera and Personalis Partner for Personalized Monitoring in Oncology

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, and Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced that the two companies have entered...

PSNL : 30.83 (-2.68%)
NTRA : 116.09 (+6.74%)
What's in Store for Zomedica (ZOM)This Earnings Season?

Zomedica (ZOM) may provide an update on Truforma commercialization progress when it reports fourth-quarter 2020 results.

ZOM : 1.8700 (+1.08%)
BHC : 31.42 (+0.45%)
PSNL : 30.83 (-2.68%)
BCEL : 17.35 (-2.25%)
What's in Store for Mallinckrodt (MNKKQ)This Earnings Season?

Negative impact of COVID-19 is likely to have hurt sales of Mallinckrodt (MNKKQ) during the fourth quarter. Investors are likely to focus on bankruptcy proceedings during the earning call.

BHC : 31.42 (+0.45%)
PSNL : 30.83 (-2.68%)
BCEL : 17.35 (-2.25%)
MNKKQ : 0.3905 (-4.76%)
Personalis Expands Leadership Team with Appointment of Susan Moriconi, VP of People and Chief Human Resources Officer

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced the appointment of Susan Moriconi as VP of People and Chief Human Resources Officer....

BSX : 38.78 (-2.24%)
PSNL : 30.83 (-2.68%)
OMCL : 126.90 (-0.24%)
PSNL Crosses Above Average Analyst Target

In recent trading, shares of Personalis Inc have crossed above the average analyst 12-month target price of $33.17, changing hands for $35.05/share. When a stock reaches the target an analyst has set,...

PSNL : 30.83 (-2.68%)
Personalis Announces the Launch of NEOPS(TM), a Neoantigen-based Composite Biomarker for Cancer Immunotherapy Response

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of its proprietary Neoantigen Presentation Score (NEOPS). NEOPS combines analysis from Personalis'...

OSUR : 10.60 (-0.84%)
PSNL : 30.83 (-2.68%)
Personalis Announces the Launch of SHERPA(TM) for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of its Systematic HLA Epitope Ranking Pan Algorithm (SHERPA), the company's proprietary, machine learning-based...

OSUR : 10.60 (-0.84%)
PSNL : 30.83 (-2.68%)
Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates

Personalis (PSNL) delivered earnings and revenue surprises of 10.00% and 2.96%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

PSNL : 30.83 (-2.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.

See More

Key Turning Points

3rd Resistance Point 35.59
2nd Resistance Point 33.86
1st Resistance Point 32.35
Last Price 30.83
1st Support Level 29.10
2nd Support Level 27.36
3rd Support Level 25.85

See More

52-Week High 53.46
Fibonacci 61.8% 34.67
Last Price 30.83
Fibonacci 50% 28.86
Fibonacci 38.2% 23.06
52-Week Low 4.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar